Medication after weight-loss surgery for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial looks at whether a specific diabetes medicine given after bariatric (weight-loss) surgery can improve blood sugar control in people with type 2 diabetes. You might be considered if you are eligible for this surgery and meet the weight criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- Your body mass index (BMI) is over 30
- You are eligible for bariatric (weight-loss) surgery based on NICE rules
- You have not been in the hospital in the last 30 days
- You have not had repeated dangerous low blood sugar episodes
- You are not pregnant or breastfeeding, and you have not had bariatric surgery before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two weight-loss operations (sleeve gastrectomy or Roux-en-Y gastric bypass) can improve type 2 diabetes. It may help people with higher body weight and diabetes control, but it also requires meeting safety and health criteria.
This study tests whether bariatric (weight-loss) surgery can improve blood sugar control in people with obesity and either prediabetes or type 2 diabetes. You may be enrolled in one of these glucose groups, and the researchers will monitor changes before and after surgery.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This study tests whether weight-loss surgery improves how your body uses insulin and energy. It compares insulin sensitivity and related measurements before and after surgery to understand who benefits.
This study tests if adding a GLP-1 medication to weight-loss surgery helps people with obesity and related conditions like diabetes. It may improve weight loss and blood sugar control more than surgery alone.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.